Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Titel:
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Auteur:
Kron, A. Alidousty, C. Scheffler, M. Merkelbach-Bruse, S. Seidel, D. Riedel, R. Ihle, M.A. Michels, S. Nogova, L. Fassunke, J. Heydt, C. Kron, F. Ueckeroth, F. Serke, M. Krüger, S. Grohe, C. Koschel, D. Benedikter, J. Kaminsky, B. Schaaf, B. Braess, J. Sebastian, M. Kambartel, K -O Thomas, R. Zander, T. Schultheis, A.M. Büttner, R. Wolf, J.